GHK-CU

This abstract synthesizes current knowledge regarding the human GHK-Cu peptide's regenerative and protective biological actions. It integrates existing understanding with recent genetic data to elucidate the molecular mechanisms underlying its diverse effects. The review focuses on the peptide's activity within human biological systems, including various human tissues and cell types like dermal fibroblasts and COPD fibroblasts.

The peptide GHK-Cu is identified as possessing numerous health-positive actions. These include stimulating blood vessel and nerve outgrowth, enhancing the synthesis of collagen, elastin, and glycosaminoglycans, and supporting dermal fibroblast function. Furthermore, GHK-Cu exhibits significant cell protective properties, such as anti-cancer and anti-inflammatory activities, lung protection, restoration of COPD fibroblasts, suppression of aging-related molecules like NFκB, DNA repair, and activation of the proteasome system for cell cleansing. These varied healing and protective actions are explained by GHK-Cu's regulation of multiple biochemical pathways, as revealed by new genetic insights.

This abstract synthesizes existing research on GHK and GHK-Cu, focusing on its potential role as an anti-aging peptide. It compiles evidence from various sources, including human serum data, in vitro studies, in vivo studies, and preliminary observations in aging mice. This comprehensive review aims to establish a rationale for further investigation into GHK within preclinical and clinical aging research contexts.

Naturally occurring GHK levels in human serum significantly decrease with age, falling from an average of 200 ng/ml at age 20 to 80 ng/ml by age 60. Both GHK and its copper chelate, GHK-Cu, demonstrate anti-inflammatory and tissue remodeling properties. GHK-Cu has been shown to promote skin remodeling, wound healing, and regeneration, along with exhibiting prominent antioxidant and anti-inflammatory effects across various experimental models, including preliminary findings in aging mice suggesting a partial reversal of cognitive impairment.

This in vitro study explored liposomes as potential carriers for the anti-aging and wound-healing peptide, GHK-Cu. Anionic and cationic hydrogenated lecithin-based liposomes were prepared using a thin-film hydration method, combined with freeze-thaw cycles and extrusion. The investigation focused on how lipid content, composition, and GHK-Cu concentration affected liposome physicochemical properties, lipid bilayer fluidity, and encapsulation efficiency.

Stable GHK-Cu-loaded liposome systems, approximately 100 nm in size, were successfully produced. Cationic liposomes exhibited greater bilayer fluidity, and optimal carriers were identified as 25 mg/cm3 cationic or anionic liposomes loaded with 0.5 mg/cm3 GHK-Cu, achieving encapsulation efficiencies of 31.7% and 20.0%, respectively. While GHK-Cu did not significantly alter tyrosinase activity in these in vitro assays, it resulted in 48.90% elastase inhibition, suggesting a potential role in mitigating elastin degradation.

This review evaluated the potential of glycyl-histidyl-lysine peptide (GHK) and its derivatives, GHK-Cu and Pal-GHK, as topical anti-wrinkle agents. It aimed to determine their effectiveness in wrinkle prevention or reduction and assess their skin permeability. The review synthesized information from existing literature, primarily drawing conclusions about efficacy from cellular studies and examining various skin permeation enhancement methods.

Based on cellular studies, GHK demonstrates potential as an anti-wrinkle ingredient. Although GHK-Cu and Pal-GHK are considered effective and relatively skin permeable, there is a notable absence of clinical studies directly involving these specific derivatives. Permeation can be successfully increased through methods like metal complexation, chemical modification with hydrophobic moieties, incorporating cell-penetrating peptides, and potentially microneedle pretreatment, which helps overcome challenges associated with their hydrophilic and unstable nature.

This peer-reviewed abstract describes a literature review investigating GHK's multifaceted role in skin regeneration. It synthesizes findings from in vitro studies, animal models including dogs, rats, mice, and pigs, and observations from human cosmetic applications. The review focuses on how GHK, often complexed with copper, influences various cellular pathways relevant to tissue repair.

GHK, particularly when complexed with copper, is found to accelerate wound healing and skin repair across different tissues and species. It modulates both the synthesis and breakdown of collagen and glycosaminoglycans, stimulates specific matrix components like decorin, and influences metalloproteinase activity. Mechanistically, it restores fibroblast vitality, attracts immune and endothelial cells, and can up- or downregulate approximately 4,000 human genes, suggesting a broad impact on cellular health and regenerative processes.

This narrative review aimed to evaluate the current evidence and applications of injectable peptide therapy, focusing on its potential in regenerative medicine and sports performance for orthopaedic providers. It involved a comprehensive literature search using PubMed to identify biochemical and clinical studies on popular injectable peptides. The review primarily assessed evidence from preclinical models, animal studies, and existing human trials or case series.

For GHK-Cu, the review identified promising findings in wound healing and anti-inflammatory effects from non-clinical data. However, it explicitly notes that no clinical data currently support its use for musculoskeletal conditions. This underscores a significant lack of evidence for GHK-Cu's clinical application, indicating that substantial research into its safety and efficacy is necessary before any definitive recommendations can be made.

This article is a review of therapeutic peptides in orthopaedics. It integrates current mechanistic insights with orthopaedic relevance, drawing primarily from existing preclinical studies. The review notes a current lack of clinical trials for these peptides.

Therapeutic peptides influence tissue regeneration, inflammation resolution, and neuromuscular recovery by modulating key signaling networks like PI3K/Akt, mTOR, and TGF-β. GHK-Cu is highlighted as a wound-healing peptide that promotes angiogenesis, integrin-mediated extracellular matrix remodeling, and fibroblast activation. While preclinical research shows promise for such peptides, further clinical investigation is needed to establish safety and efficacy.